2-hydroxy-7-methoxy-2H-1,4-benzoxazin-3-one: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 152213 |
| CHEMBL ID | 451316 |
| CHEBI ID | 179371 |
| SCHEMBL ID | 914279 |
| MeSH ID | M0105546 |
| Synonym |
|---|
| 2-hydroxy-7-methoxy-2h-1,4-benzoxazin-3(4h)-one |
| 17359-53-4 |
| CHEBI:179371 |
| 2-hydroxy-7-methoxy-4h-1,4-benzoxazin-3-one |
| hmboa |
| 2-hydroxy-7-methoxy-1,4-benzoxazin-3-one |
| CHEMBL451316 |
| 2h-1,4-benzoxazin-3(4h)-one, 2-hydroxy-7-methoxy- |
| 2-hydroxy-7-methoxy-2h-1,4-benzoxazin-3-one |
| SCHEMBL914279 |
| 2-hydroxy-7-methoxy-3,4-dihydro-2h-1,4-benzoxazin-3-one |
| 7-methoxy-2h-1,4-benzoxazine-2,3-diol |
| DTXSID30938408 |
| BCP31439 |
| 2-hydroxy-7-methoxy-1,4-benzoxazin-3-one; 2h-1,4-benzoxazin-3(4h)-one, 2-hydroxy-7-methoxy- |
| A904257 |
| 2-hydroxy-7-methoxy-2h-benzo[b][1,4]oxazin-3(4h)-one |
| Class | Description |
|---|---|
| benzoxazine | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1103171 | Antifeedant activity against third-instar larvae of Rhopalosiphum padi assessed as repellency index after 24 hr by feeding choice assay | 2004 | Journal of agricultural and food chemistry, May-05, Volume: 52, Issue:9 | Chemical basis for the antifeedant activity of natural hydroxamic acids and related compounds. |
| AID338667 | Antiinflammatory activity in Wistar rat peritoneal mast cells assessed as inhibition of concanavalin A-induced histamine release treated 10 mins before concanavalin A challenge measured after 30 mins | |||
| AID338669 | Antiinflammatory activity in Wistar rat peritoneal mast cells assessed as inhibition of IgE-induced histamine release at 1000 uM treated 10 mins before IgE challenge measured after 5 mins | |||
| AID338668 | Antiinflammatory activity in Wistar rat peritoneal mast cells assessed as inhibition of concanavalin A-induced histamine release at 1000 uM treated 10 mins before concanavalin A challenge measured after 30 mins | |||
| AID1585947 | Antifungal activity against Candida albicans after 24 hrs by spectrophotometric method | 2018 | Bioorganic & medicinal chemistry, 12-15, Volume: 26, Issue:23-24 | QSAR of 1,4-benzoxazin-3-one antimicrobials and their drug design perspectives. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.36) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||